Friday, December 13, 2019

$30.13 Billion Global Psoriasis Drugs Market Size, Growth, Segmentation And Forecast Report

Psoriasis Drugs Market


The Business Research Company’s Psoriasis Drugs Market covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

The psoriasis drugs market consists of sales of psoriasis drugs. Psoriasis is a persistent skin disorder which causes distress and pain through patches of abnormal skin. Psoriasis can be caused due to injuries to skin, medications, genetics, infection, diet, weather, etc. The drugs vary depending on the severity of the infection and provide relief from infections. Examples of drugs in the psoriasis market include Clobetasol (Temovate), triamcinolone (Aristocort), fluocinolone (Synalar), and betamethasone (Diprolene).

Major players in the market are AbbVie Inc., Pfizer Inc., Novartis, Eli Lilly and Company and Celgene Corporation.


The rise in the prevalence of psoriasis patients is driving the Psoriasis market. Psoriasis is caused due to immune system, genetics and environment. The rise in psoriasis patients in the past few years can be mainly attributed to climate change, stress and unhealthy lifestyle. According to the World Health Organization (WHO), psoriasis had affected at least 100 million individuals worldwide in 2016.
The high cost of psoriasis therapy is a restraint for the psoriasis market. According to a study conducted by JAMA Dermatology in 2019, the typical psoriasis treatments with biologics are very costly, ranging between $10,000 and $25,000 per year. The high cost is because patent protections are preventing many alternative drugs.


The high cost of psoriasis therapy is a restraint for the psoriasis market. According to a study conducted by JAMA Dermatology in 2019, the typical psoriasis treatments with biologics are very costly, ranging between $10,000 and $25,000 per year. The high cost is because patent protections are preventing many alternative drugs.

North America was the largest region in the psoriasis drugs market in 2018. This region is expected to remain the largest during the next five years. The psoriasis drugs market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.

Browse Year End Discounted Reports Offered By TBRC @ https://www.thebusinessresearchcompany.com/discounted-reports.aspx

About Us:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

$17.88 Billion Global Dermatitis Drugs Market Size, Growth, Segmentation And Forecast Report

Dermatitis Drugs Market

The Business Research Company’s Dermatitis Drugs Market covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

The dermatitis drugs market consists of sales of dermatitis drugs such as corticosteroids, calcineurin inhibitors, PDE4 inhibitors which are used to cure inflammation of the outer layer of the body, characterized by itchy rashes on swollen and reddened skin. Some of the major dermatitis drugs include Triamcinolone, Clobetasol, Betamethasone, Hydrocortisone, Fluocinonide and Clobex.
Major players in the market are LEO Pharma A/S, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc. and Sanofi S.A.


Growth in Atopic Dermatitis market is primarily driven by the increasing global prevalence of the disease. Prevalence of dermatitis in children is estimated to be around 15-20% while it is 1-3% in adults. The rising cases of food allergies are adding to the prevalence of dermatitis which ultimately leads to the increase in demand for the medicines to cure this disease. For example, a study conducted in Norway highlights that the overall incidence rate of atopic dermatitis has increased from 0.028 per person year in 2009 to 0.034 per person year in 2014.

The strict government regulations are one of the restraints for the dermatitis drug market. Atopic Dermatitis (eczema) usually occurs at a very early stage (0-5 years). In order to find the efficacy and efficiency of drug, it has to be tried on the every type of patients. The effects of certain drugs in adults are quite different than in children, as a reason results of the clinical trial cannot be used for the production of drug that will be served to the children. This hinders the research and requires more efforts in clearing regulation set by FDA. For example, as the patient population is largely children, FDA in its CFR Code Title 21, Part 50 Protection of Human Subjects, and subpart D has laid down guidelines for the additional safeguard for children in clinical investigation. The regulation is in compliance with Children’s Health Act of 2000 that requires all the children subjected to clinical trial be given additional protection.


The Dermatitis market has witnessed a trend of increasing Mergers and Acquisitions (M&As), done with the purpose of business expansion and increasing visibility. M&As are playing a significant role in today's world and are assumed to expand this market in the years to come. The vendors in this industry are focusing on collaboration and partnerships to expand their portfolio and improve market presence. Companies are also strategically making M&As with a view to reduce competition and increase the scalability of their business. 

Browse Year End Discounted Reports Offered By TBRC @ https://www.thebusinessresearchcompany.com/discounted-reports.aspx

About Us:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
View Our Latest Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

$15.45 Billion Global Acne Drugs Market Size, Growth, Segmentation And Forecast Report

Acne Drugs Market


The Business Research Company’s Acne Drugs Market covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

The acne drugs market consists of sales of prescription acne drugs (Salicylic acid, Retin-A Micro, Onexton, and Solodyn) and related OTC non-prescription products (cleansers, lotions, gels, toners, masks and pads containing acne-fighting ingredients) which are used to treat skin diseases such as acne vulgaris and acne rosacea. Based on the type of acne, this market is segmented into inflammatory acne and Non-Inflammatory acne. Market in this report does not include the sales of drugs used for Dermatitis and Psoriasis.

Major players in the market are ALLERGAN, Galderma S.A., Valeant Pharmaceutical International Inc., Teva Pharmaceutical Industries Ltd. and Johnson & Johnson Services, Inc.

Bottom of Form

An increase in the disposable income of people is one of the major drivers in the acne market. An increase in the disposable income is usually due to an improved economy leading to increased wages and salaries boosting healthcare expenditure. In 2018, Disposable Income in India increased 13.67% when compared to 2017 i.e. from 169 million INR to 192 million INR. Rise in disposable income increased expenditure on facial care products is expected to continue, thereby driving the market in the forecast period.

Acne is a major problem worldwide, close to 90% of people suffer from some sort of acne. In America alone, close to 12 million people suffer from a severe acne problem, that can lead to scarring of the skin if left untreated, as a result many people purchase Acne care drugs and products.
The presence of alternatives for acne treatment is one of the restraint on the acne drugs market. Due to availability of multiple alternatives, patients tends to choose one amongst many options on the basis of price, side effects, duration and many more. This increases the competition and hence, the competition cuts down a significant portion of business for the acne drugs market. For example, some of the alternatives for the acne treatment apart from acne drugs are Ayurveda, home remedy, laser and photodynamic therapy and extraction of whiteheads and blackheads using special tools like needles and forceps.


Combination therapy is the latest trend in the acne market. Combination therapy is the process of combining two drugs with different mechanisms of action, such combinations of medication have a better efficacy and adherence when compared with monotherapy (the use of only a single drug by itself).The combination of a topical retinoid drug, which unclogs the pores, along with an antimicrobial drug, which is used to treat an infection is being used to treat acne. Example of combination therapy includes: Epiduo, Acanya, Ziana and Benzamycin produced by Galderma, Allergan, Medicis and Atrix respectively.

Browse Year End Discounted Reports Offered By TBRC @ https://www.thebusinessresearchcompany.com/discounted-reports.aspx

About Us:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Thursday, December 12, 2019

Blood Glucose Test Strips Market | Global Blood Glucose Test Strips Market Research Report


Global Blood Glucose Test Strips Market - Industry Segment Analysis, Regional Outlook, Market Size, Market Share, Market Growth; Blood Glucose Test Strips Market Forecast Report 2021

Read More @ https://www.thebusinessresearchcompany.com/report/blood-glucose-test-strips-market

Anti-Infective Drugs Market | Global Anti-Infective Drugs Market Research Report



Global Anti-Infective Drugs Market - Industry Segment Analysis, Regional Outlook, Market Size, Market Share, Market Growth; Anti-Infective Drugs Market Forecast Report 2022

Read More @ https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

$3.3 Billion Global Nuclear Imaging Devices And Equipment Market Size, Growth, Segmentation And Forecast Report

Nuclear Imaging Devices And Equipment Market


The Business Research Company’s Nuclear Imaging Devices And Equipment Market covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

The nuclear imaging devices and equipment market consists of sales of nuclear imaging devices and related services. Nuclear imaging devices and equipment are used in the diagnosis of radioactive substances in the patients. The key product types of the market include SPECT (single-photon emission computed tomography) systems (hybrid SPECT and standalone SPECT) and hybrid PET systems. These products are used in a wide range of medical applications including cardiology, obstetrics/gynecology, vascular, urology, and other medical applications.

Major players in the market are Toshiba Medical Systems Corporation, Neusoft Medical Systems Co., Ltd., SurgicEye GmbH, Siemens Healthineers and GE Healthcare.


The nuclear imaging devices and equipment market is being driven by increasing incidences and prevalence of diseases such as cancer, heart disease, gastrointestinal, endocrine and neurological disorders. Such diseases are diagnosed in relatively early stages by nuclear imaging equipment as compared to other equipment. For instance, according to the international agency for research on cancer (IARC), the cancer occurrences have increased to 18.1 million new cases and 9.6 million cancer deaths in 2018, many of which have been diagnosed by nuclear imaging devices and equipment.

The nuclear imaging devices and equipment market is being restrained by strict regulations by the Nuclear Regulatory Commission (NRC) medical use. For instance, the NRC requires nuclear imaging equipment licensees to use and store radioactive materials to protect workers and common people by removing unwanted exposure, which has resulted in a relatively less number of nuclear imaging equipment being manufactured.


The Nuclear Regulatory Commission (NRC), USA regulates the manufacture and use of radioactive materials in nuclear imaging devices, as well as radiation therapy and research. It has agreements with 37 US states which allows them to regulate the use of certain radioactive materials by giving licenses to hospitals, clinics and medical centers. The US based Food and Drug Administration (FDA) also regulates products and procedures that are radiation-emitting. It reviews the safety and use of radiopharmaceuticals and machines like x-rays, which produce radiation but do not make or use radioactive material.

Browse Year End Discounted Reports Offered By TBRC @ https://www.thebusinessresearchcompany.com/discounted-reports.aspx

About Us:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
View Our Latest Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

$7.6 Billion Global Magnetic Resonance Imaging Devices And Equipment Market Size, Growth, Segmentation And Forecast Report | MRI Market Report

Magnetic Resonance Imaging Devices And Equipment Market


The Business Research Company’s Magnetic Resonance Imaging Devices And Equipment Market covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

The magnetic resource imaging devices and equipment market consists of sales of magnetic resource imaging systems devices and equipment and related services. Magnetic resonance imaging (MRI) systems are imaging machines used to form pictures of inflammation or infection in an organ, degenerative diseases, strokes, musculoskeletal disorders, tumors, and other irregularities that exist in tissue or organs in a body. MRI systems use a fixed or static magnetic field and radio frequency signals to visualize anatomy, tissue characteristics, vascular flow, chemical composition of tissues, and perfusion and diffusion of tissues.

Major players in the market are Siemens Healthineers, GE Healthcare, Philips Healthcare, Hitachi Ltd. and Canon Medical Systems.


Changes in the lifestyle, technological advancement and increase in number of chronic diseases are increasing the demand for the diagnostics, driving the growth of MRI systems market. Magnetic resonance imaging (MRI) systems are used to produce three dimensional detailed anatomical images of the human body facilitating diagnosis, disease detection and treatment monitoring. The rising health concerns are increasing the demand for medical imaging technologies in healthcare centers for diagnosis. For instance, in India, 150,000 health and wellness centers with a budget of $ 1.8 billion enable the healthcare system more accessible. Increasing health consciousness and importance to health insurance is also causing significant growth in the market.

Strict approvals and regulations by government bodies such as US Food and Drug Administration (FDA) is hampering the growth of magnetic resonance imaging systems, devices and equipment market. MRI systems manufacturers are required to comply several regulations in the form of device quality check, labeling, premarket approval, device investigation and reporting, apart from the regular registration process. Due to these stringent regulations, many manufacturers prefer to outsource the manufacturing to other countries where no such regulations are imposed. For instance, in July 2017, the European Medicines Agency (EMA), restricted the use of some linear gadolinium agents used in MRI body scans and to suspend the authorizations of others, as the gadolinium deposits are found in the brain after MRI scans. EMA has recommended these restrictions and suspensions in order to prevent any risks that could potentially be associated with gadolinium brain deposition.


The EU agencies and US-FDA require 3 to 7 years along with all parts of the registration dossier to be submitted to approve the medical devices. The US-FDA assess each technical section for 6 months which may increase to another 6 months cycle if questions/concerns are raised. However, the technical sections’ assessment is done simultaneously and therefore the manufacturers should identify the time taking processes and plan the work accordingly and plan estimated date of approval. 

 Browse Year End Discounted Reports Offered By TBRC @ https://www.thebusinessresearchcompany.com/discounted-reports.aspx

About Us:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

$2.36 Billion Global Electrophysiology Devices And Equipment Market Size, Growth, Segmentation And Forecast Report

Electrophysiology Devices And Equipment Market


The Business Research Company’s Electrophysiology Devices And Equipment Market covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

The electrophysiology devices and equipment market consists of sales of electrophysiology devices and equipment and related services. Electrophysiology devices and equipment are used in the diagnosis and treatment of heart rhythm disorders through electrical activity. The market is segmented by product type into electrophysiology ablation catheters, electrophysiology diagnostic catheters and electrophysiology lab systems.

 Major players in the market are St. Jude Medical, Boston Scientific Corporation, Abbott Laboratories, GE Healthcare and Philips Healthcare.


Increase in prevalence rate of cardiovascular diseases (CVD) forms one of the major driver for the industries operating in electrophysiology devices and equipment market. CVD cases remains the leading cause of death across globe, which increases the demand for a quick and effective treatment of the disease, thus increasing the demand for electrophysiology devices. According to the data released by American Heart Association (AHA) in 2019, at least 48% of all the adults in the USA have some form of cardiovascular disease. CVD prevalence excluding high blood pressure among adults in the USA is 9% (24.3 million in 2016). Also, according to the Centers for Disease Control and Prevention (CDC), in 2017, 2.7 to 6.1 million people in the USA were suffering from atrial fibrillation, which is the most common type of heart arrhythmia.

Lack of uniformity in the regulations governing the electrophysiology devices and equipment industry sometimes restrict the companies in the market from expanding globally, thereby hampering the market’s growth. The impact of individual country regulatory requirements can have huge implications to the availability of new electrophysiology devices and equipment. According to regulations in few geographies, the manufacturers are required to conduct clinical trials (premarket and/or post-market) be either in whole or in part within a country. However, in markets such as Brazil, Japan, India, and China where local regulations are still in nascent stage, the cost to run the trials incur to the manufacturers. Example, trials for devices like cardiac rhythm management (CRM) in multiple countries has less merit, and does not reflect the true test results as it becomes difficult for the manufacturers to provide sufficient devices to run tests.


In order to increase the profit margins and sales, the companies operating in the Electrophysiology (EP) devices and equipment industry are coming up with new technologies aimed towards improving EP mapping and localization technology. EP mapping is a procedure used to diagnose the origins of the abnormal heart rythms. This procedure uses an electrically sensitive catheter. With improved mapping technologies it becomes easy to detect and locate the abnormalities in heart. 

 Browse Year End Discounted Reports Offered By TBRC @ https://www.thebusinessresearchcompany.com/discounted-reports.aspx

About Us:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Wednesday, December 11, 2019

Wearable Medical Devices Market | Global Wearable Medical Devices Market Research Report



Global Wearable Medical Devices Market - Industry Segment Analysis, Regional Outlook, Market Size, Market Share, Market Growth; Wearable Medical Devices Market Forecast Report 2022

Read More @ https://www.thebusinessresearchcompany.com/report/wearable-medical-devices-market

Global 3D Printing Devices, Services And Supplies Market Growth And Trends



3D Printing Devices, Services And Supplies Market - Industry Segment Analysis, Regional Outlook, Market Size, Market Share, Market Growth; 3D Printing Devices, Services And Supplies Market Forecast Report 2022

Read More @ https://www.thebusinessresearchcompany.com/report/3d-printing-devices-services-and-supplies-market

$8.5 Billion Global Spinal Surgery Devices And Equipment Market Size, Growth, Segmentation And Forecast Report



The Business Research Company’s Spinal Surgery Devices And Equipment Market covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.
The spinal surgery devices and equipment market consists of sales of spinal surgery devices and equipment and related services. These include spinal implants and spinal surgical devices such as thoracic fusion and lumbar fusion devices, spine biologics, cervical fusion devices, vertebral compression fracture treatment devices, spine bone stimulators, non-fusion devices and spinal decompression devices.
Major players in the market are Zimmer Biomet, Stryker Corporation, Depuy Synthes, Medtronic and Globus Medical Inc.
Elderly people are a major driving factor for the spinal surgery devices and equipment market as they are more prone to spinal complications. Spinal disorders majorly affect the geriatric population and results in spinal deformities and pain. As per UN 2017 estimates, worldwide geriatric population will double by 2050 to reach an estimated value of more than 2.1 billion boosting market growth in the future. Increasing trend in the aged populations worldwide will provide a lucrative growth to the spinal implants and devices.
Take a look at our year-end deals on Opportunities and Strategies Reports! Up to 50% off on all licenses @ https://www.thebusinessresearchcompany.com/discounted-reports.aspx
The high cost of treatment restrains the spinal surgery devices and equipment market from reaching its maximum potential growth. According to a study conducted over a year to analyze cost variations, the total cost of the surgeries at the hospitals was found to vary between $27, 000 and $129,000. More than $90 billion a year is spent on treating lower back pain alone. Due to the steadily increasing cost of procedures the rate of implementing spinal surgery devices has come down this a major restraint for the large scale hospitals, clinics as well as new entrants for the market.
Implementing Nano-technology to improve the quality, precision and speed of the work is the latest trend in the spinal surgery devices market. Nanoparticles possess unique chemical, biological and physical properties which enables them to perform a wide variety of cellular and subcellular tasks. Spinal pathology is a major field of study for Nano-technology. To fully implement Nano-technology, hospitals and clinics are waiting for FDA regulations and exploring options to reduce costs.
Browse Year End Discounted Reports Offered By TBRC @ https://www.thebusinessresearchcompany.com/discounted-reports.aspx
About Us:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
View Our Latest Blog Reports: http://blog.tbrc.info/

$2.01 Billion Global Blockchain Technologies Market Size, Growth, Segmentation And Forecast Report




The Business Research Company’s Blockchain Technologies Market covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.
The block chain technologies market consists of sales of block chain technologies and related services. Block chain is a technology which involves the implementation of a distributed database that is accessible to all the users over a network. Each user can add a new data record (block), with a timestamp that cannot be altered. Each new block forms a part of the universally acceptable depository. The block chain technology maintains the authentication of data by restricting changes in the older data blocks while allowing the users to continue adding new data blocks thus, making the manipulation of data such as faking documents or transactions and other information, impossible. The block chain technology is used to create digital contracts and in domains such as financial, healthcare and insurance.
Major players in the market are IBM, AWS, Microsoft Corporations, Ripple and Circle Internet Financial Limited.
Companies across various industries are increasingly investing in block chain technology due to its high efficiency in data management. The block chain technology is growing strongly in major sectors such as healthcare, banking and finance, digital assets, and also in several government departments. Thus, companies like VISA, Facebook, Microsoft and Amazon are investing in the technology to integrate block chain with their daily operations at an early stage. Companies use block chain technology to create smart contracts, this helps to speed up the payment processes as well as provides support while investing in the stock exchange. In 2018, Diar, a block chain research group, reported that block chain focused start-ups have used various venture capital funding methods to raise close to $3.9 billion.
Take a look at our year-end deals on Opportunities and Strategies Reports! Up to 50% off on all licenses @ https://www.thebusinessresearchcompany.com/discounted-reports.aspx
The growth of the block-chain technology market is being restrained due to the security vulnerabilities that companies in this market are facing due to the weak systems and human errors. The platforms used to interact with the block-chain technology lacks necessary security. The bock chain industry lost an estimated amount of $3.55 billion between 2011 and 2018, because of the technical flaws leading to lack of security in block chain technology. For instance, Mt. Gox, a Japanese cryptocurrency company, collapsed when it lost $450 million worth of bitcoins, this was due to security breaches between 2011 and 2014. In another instance reported in January 2018, a Tokyo-based cryptocurrency exchange named Coincheck suffered a loss of $534.8 million when a hacker used hacking software and unethically transferred NEM (New Economy Movement) coins worth more than $500 million to his account. NEM is a peer to peer (P2P) cryptocurrency launched in 2015. A P2P cryptocurrency is a digital or virtual currency exchange that takes place between the two parties without the intervention of any middlemen. These transactions are made over the block chain network.
About Us:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
View Our Latest Blog Reports: http://blog.tbrc.info/

$2.26 Billion Global Biostimulants Market Size, Growth, Segmentation And Forecast Report

Biostimulants Market


The Business Research Company’s Biostimulants Market covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.
The bio stimulants market consists of sales of bio stimulants and related services. Bio stimulants include diverse formulations of compounds and micro-organisms that improve crop yields, quality and tolerance to abiotic stresses
Major players in the market are BASF, Valagro, Bayer, Koppert Biological Systems and Italpollina.
Increasing focus of farmers to improve crop quality and yield is driving the bio stimulants market. Excessive use of chemical fertilizers and frequent cultivation has led to soil degradation and crops produced in these conditions are devoid of nutrients. Bio stimulants are eco-friendly and provide more nutritious food than chemical fertilizers. The Food And Agricultural Organization (FAO) estimates that by the year 2050, crop yield need to increase by 60% of what it was in the year 2007 to meet the demand of increasing population. The need for improved yields and quality is driving growth of the bio stimulants market.
Lack of awareness about bio stimulants and its usage among farmers is acting as a restraint on the bio stimulants market. Farmers are not aware of the benefits of bio stimulants and continue to rely on chemical fertilizers for plant growth. For instance, according to Biostadt India Ltd., only 40% of farmers in India are using bio stimulants mainly due to lack of awareness.
Bio stimulants manufacturers are forming strategic alliances with other companies in the bio stimulants market to expand product portfolios and enter into new markets. Partners in strategic alliances may provide resources such as distribution channels, funding, manufacturing capacity, knowledge and others. For example, in 2018, COMPO EXPERT GmbH, a manufacturer of bio stimulant has entered into a strategic alliance with India based fertilizer manufacturing firm Transworld Furtichem Pvt. Ltd. to manufacture environment friendly bio stimulants. In 2018, Compo Expert also entered into a strategic partnership with PlantResponse.
Take a look at our year-end deals on Opportunities and Strategies Reports! Up to 50% off on all licenses @ https://www.thebusinessresearchcompany.com/discounted-reports.aspx
Europe was the largest region in the bio stimulants market in 2018, followed by Asia Pacific and North America respectively. This region is expected to remain the largest during the next five years. The bio stimulants market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.
About Us:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
View Our Latest Blog Reports: http://blog.tbrc.info/


Tuesday, December 10, 2019

Organ-On-Chip Market | Global Organ-On-Chip Market Research Report

organ on chip market


Global Organ-On-Chip Market - Industry Segment Analysis, Regional Outlook, Market Size, Market Share, Market Growth; Organ-On-Chip Market Forecast Report 2021

Minor Orthopedic Implants Replacement Market | Global Minor Orthopedic Implants Replacement Market Research Report

Minor Orthopedic Implants Replacement Market

Global Minor Orthopedic Implants Replacement Market - Industry Segment Analysis, Regional Outlook, Market Size, Market Share, Market Growth; Minor Orthopedic Implants Replacement Market Forecast Report 2022


$27.38 Billion Global Surveillance Technology Market Size, Growth, Segmentation And Forecast Report

Surveillance Technology Market



The Business Research Company’s Surveillance Technology Market covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

The surveillance technology market consists of sales of surveillance technology and related services. Surveillance technologies are used to monitor a place, person or object in a particular geographical location. Surveillance systems are utilized for monitoring activities of workers, traffic and potentially illegal activities. Surveillance technology includes surveillance systems based on video, audio or biometrics.
Major players in the market are Dahua Technology, Axis Communications, Panasonic, Honeywell Security and Bosch Security Systems.


The effectiveness of surveillance technology in reducing crimes is one of the key drivers for the surveillance technology market. This is mainly due to high success rate of surveillance systems based on advanced technologies that help in reducing crimes. Most crimes which earlier depended on eye-witness accounts can now be easily solved with the help of surveillance systems such as surveillance camera. For example, according to an article review published in the Journal of Scandinavian Studies in Criminology and Crime Prevention in 2017, CCTVs reduced crime by 24-28% in public streets and urban subway stations.

The privacy concerns associated with the use of surveillance systems acts as a major restraint on the surveillance technology market. With the advancement in surveillance technology, it has become easier for the governments as well as corporates to monitor the movements of citizens and employees. While surveillance by the government is beneficial in recognizing potential threats, it has become a major privacy concern for the general public. For instance, according to an online survey conducted by Pew Research Center in early 2015, around 52% Americans described themselves “very concerned” or “somewhat concerned” about government surveillance of Americans’ data and electronic communications stating it as "invasion of privacy" by the government. Similarly, a 2018 survey by Gartner found that 22% of organizations worldwide are using employee-movement data, 17% are monitoring work-computer-usage data, and 16% are using Microsoft Outlook- or calendar-usage data. This surveillance by the corporates raises a concern of invasion of privacy among the employees, and thus, is a restraint to the surveillance technology market.

Take a look at our year-end deals on Opportunities and Strategies Reports! Up to 50% off on all licenses @ https://www.thebusinessresearchcompany.com/discounted-reports.aspx

The surveillance technology market has been geographically segmented into North America, Western Europe, APAC, Eastern Europe, South America and Middle East & Africa. The APAC market is the largest market for surveillance technology and is expected to continue to be the largest market during the forecast period.


About Us:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
View Our Latest Blog Reports: http://blog.tbrc.info/

$74.85 Billion Global Productivity Software Publishing Market Size, Growth, Segmentation And Forecast Report

Productivity Software Publishing Market


The Business Research Company’s Productivity Software Publishing Market covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

The Productivity Software Publishing market consists of sales of productivity software. Productivity software is an application dedicated to producing information, such as documents, presentations, worksheets, databases, charts, graphs, digital paintings, electronic music and digital video, excluding operating systems.

Major players in the market are Microsoft Corporation, IDoneThis, Oracle, Google (Alphabet Inc), IBM


Automation in any field would increase the efficiency and would therefore increase the profit margins. The productivity software publishing market is driven by the cloud based technology. The cloud based productivity software allows all the team members to share, collaborate and communicate on projects effectively not having to physically meet/share anything on disc/USB. The cloud-based software enhances the work flow by making it simpler and easy to work with. This easy platform could deliver many applications involving the graphics software, spreadsheet applications, database management systems and word processors to the end users. Also, the cloud-based software controls, safeguards and install the software automatically without having to physically monitor it. Due to the software’s ability to turn the technical power of these software tools into strategic action, managers are better positioned to gain visibility into how workers are fulfilling their responsibilities and take steps to ensure they reach crucial milestones. Examples of cloud-based productivity software includes Microsoft office 365, Zoho office online suite, Apple iWork etc.

Interoperability is defined as the ability of computer systems or software to exchange and make use of information. While the other definition could be, the ability of customers to use the same management tools, server images and other software with a variety of cloud computing providers and platforms. It could as well mean the ability of applications to move from one environment to the next, for example, from Savvis to Amazon, and for the applications to work exactly the same in both places. This challenge of compatibility of the productivity software with various systems may hinder the markets growth. For example, for moving physical applications to the Amazon EC2 cloud, first it had to convert the applications to a virtualized version before moving onto the cloud due to compatibility issues, thus increasing the costs and time required for the project.

Take a look at our year-end deals on Opportunities and Strategies Reports! Up to 50% off on all licenses @ https://www.thebusinessresearchcompany.com/discounted-reports.aspx

The Productivity Software Publishing market has been geographically segmented into North America, Western Europe, APAC, Eastern Europe, South America and Middle East & Africa. The North American Market is the largest market for Productivity Software Publishing and is expected to continue to do so during the forecast period


About Us:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
View Our Latest Blog Reports: http://blog.tbrc.info/

$20.62 Billion Global Hyperscale Data Centers Market Size, Growth, Segmentation And Forecast Report

Hyperscale Data Centers Market


The Business Research Company’s Hyperscale Data Centers Market covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

The hyperscale data centers market consists of sales of hyper scale data centers and related services. This industry includes companies that have distributed data warehouses that focus on maintaining the scalability of the data along with managing a large amount of data. Hyperscale data centers operate in buildings or dedicated space within a building, or a group of buildings that house computer systems and related components, such as telecommunications and storage systems on large scale with thousands of individual servers operating together through a high-speed network.
Major players in the market are Digital Reality, NTT and Global SWitch.


The increase in the number of internet users increases the amount of data that is generated and needs to be managed and stored by hyperscale data centers. According to Internet World Stats, the number of internet users has increased by 175% over the last decade, with almost 56% of the world population using the internet in 2019 as opposed to 28% in 2009. Telecom operators such as China Telecom, Tencent and China Unicom are expanding their business operations by constructing large-scale facilities to cater to the 731 million internet users in China. In January 2019, Tencent announced that it will build and operate several data centers for the Guangdong branch of China Telecom. Increased numbers of internet users and faster wireless internet access drive the demand for hyperscale data centers.

The hyperscale data centers require a continuous supply of high power in order to process and store the data. According to a report by Forbes Technology Council, in 2017, U.S. data centers used more than 90 billion kilowatt-hours of electricity a year. The data center facilities consume power for data-intensive operations and thus power failure puts the operations of data centers to halt. Power loss to a server causes great damage to the customers and to the business model of these hyperscale data centers. For instance, in 2018, power failure for 30 minutes affected Amazon's data center in US-EAST-2 region in Ohio and resulted in connectivity issues which impacted amazon's services like RDS (Amazon Relational Database Service), Redshift (an Internet hosting service and data warehouse product), WorkSpaces, EC2 (Amazon Elastic Compute Cloud), and EBS (Amazon Elastic Block Store), which stored their data in US-EAST-2 data center.


Take a look at our year-end deals on Opportunities and Strategies Reports! Up to 50% off on all licenses @ https://www.thebusinessresearchcompany.com/discounted-reports.aspx

The major players operating in hyperscale data market are investing to find alternatives to meet their high power requirements for existing and new facilities across the globe to reduce their carbon footprint. The leading data center providers are purchasing clean, renewable energy sources. For instance, in July 2017, Apple, announced for an investment of over $921 million for the construction of a hyperscale infrastructure facility in Denmark that will entirely operate on renewable energy sources. 


About Us:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Natural Skin Care Products Market Key Opportunities And Strategies 2023-2032

The Natural Skin Care Products Global Market Report 2023, provides comprehensive information on the natural skin care products market across...